Bases moleculares de la resistencia a betalactámicos en infecciones por Streptococcus pneumoniae

Medicina Clinica

Volumn 110, Issue SUPPL. 1, 1998, Pages 8-11

  Baquero, Fernando ^a   Blázquez, Jesús ^a   Loza, Elena ^a   Cantón, Rafael ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; GENE TRANSFER; MUTATION; NONHUMAN; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; CARRIER PROTEINS; HEXOSYLTRANSFERASES; HUMANS; MULTIENZYME COMPLEXES; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; MUTATION; PENICILLIN-BINDING PROTEINS; PEPTIDYL TRANSFERASES; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031892872     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baquero F Epidemiology and managemenl of penicillin-resistant pneumococci. Curr Opin Infect Dis 1996; 9: 372-379.
2. Dowson CG, Coftey TJ, Spratt BG. Origin and molecular epidemiology of penicillin-binding-protein-medialed resislance to beta-lactam antibiotics. Trends Microbiol 1994; 2: 361-366.
3. Dowson CG, Coffey TJ, Kell C, Whiley RA, Evolution of penicillin resistance in Streptococcus pneumoniae: the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol Microbiol 1993; 9: 635-643.
4. Sibold C, Henrichsen J, Konig A, Martin C, Chalkley L, Hakenbeck R. Mosaic pbpX genes of major clones of penicillin-resistant Streptococcus pneumoniae have evolved from pbpX genes of a penicillin-sensitive Streptococcus oralis Mol Microbiol 1994; 12: 1.013-1.023
5. Reichmann P, Konig A, Marion A, Hakenbeck R. Penicillin-binding proteins as resistance determinants in clinical isolates of Streptococcus pneumoniae. Microb Drug Resist 1996; 2: 177-181
6. Humbert O, Prudhomme M, Hakenbeck R, Dowson CG, Claverys JP. Hemeologous recombination and mismatch repair during transformation in Streptococcus pneumonias: saturation of the Hex mismatch repair system. Proc Natl Acad Sci USA 1995; 92: 9.052-9.056.
7. Baquero F, Blázque J. Evolution of antibiotic resistance. Trends Ecol Evol 1997; 12. En prensa.
8. Grebe T, Hakenbeck R, Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics. Antimicrob Agents Chemother 1996; 40: 829-834.
9. Smith AM, Klugman KP. Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 1995; 39: 859-867.
10. Klugman K, Goldstein F, Kohno S, Baquero F. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997; 3 (Supl 1): 48-60.
11. Muñoz R, Dowson CG, Daniels M, Coffey TJ, Martin C, Hakenbeck R et al. Genetics of resistance to third generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1992; 6 2.461-2.465.
12. Krauss J, Van der Linden M, Grebe T, Hakenbeck R. Penicillin-binding proteins 2x and 2b as primary PBP targets in Streptococcus pneumoniae. Microb Drug Resist 1996; 2: 183-186.
13. Yamane A, Nakano H, Asahi Y, Ubukata U, Komo M. Directly repeated insertion of 9-nucleotide sequence detected in penicillin binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40: 1.257-1.259.
14. Smith AM, Klugman KP. Alterations in PBP1a essential for high-level penicillin resistance in pneumococci. En: Resúmenes de Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto: ASM 1997 [resumen C-174].
15. Krauss J, Hakenbeck R. A mutation in the D,D-carboxypeptidase penicillin-binding protein 3 of Streptococcus pneumoniae contributes to cefotaxime resistance of the laboratory mutant C604. Antimicrob Agents Chemother 1997; 41: 936-942.
16. Severin A, Severina E, Tomasz A. Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid. Antimicrob Agents Chemother 1997; 41: 504-510.
17. Guenzi E, Gasc AM, Sicard MA, Hakenbeck R. A two-component signaltransducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol Microbiol 1994; 12: 505-515.
18. Grebe T, Paik J, Hakenbeck R. A novel resistance mechanism against beta-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase. J Bacteriol 1997; 179: 3.342-3.349.
19. Hakenbeck R, Martin C, Dowson C, Grebe T. Penicillin-binding protein 2b of Streptococcus pneumoniae in piperacillin-resistant laboratory mutants. J Bacteriol 1994; 176: 5.574-5.577.
20. Dowson CG, Johnson AP, Cercenado E, George RC. Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother 1994; 38: 49-53.
21. Negri MC, Morosini MI, Loza E, Baquero F. In vitro selective concentra lions of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother 1994; 38: 122-125.
22. Baquero F, Negri MC. Selective compartments for resistant microorganisms in antibiotic gradients. Bioassays 1997; 19: 731-736.
23. Baquero F, Negri MC. Strategies to minimize the development of antibiotic resistance. J Chemother 1997; 9 (Supl 3): 29-37.
24. Severin A, Tomasz A. Naturally occurring peptidoglycan variants of Streptococcus pneumoniae. J Bacteriol 1996; 178: 168-174.